Jack W. Callicutt
2017
In 2017, Jack W. Callicutt earned a total compensation of $406K as Chief Financial Officer at Galectin Therapeutics, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $91,163 |
|---|---|
| Salary | $260,000 |
| Other | $54,848 |
| Total | $406,011 |
Callicutt received $260K in salary, accounting for 64% of the total pay in 2017.
Callicutt also received $91.2K in bonus and $54.8K in other compensation.
Rankings
In 2017, Jack W. Callicutt's compensation ranked 12,567th out of 14,666 executives tracked by ExecPay. In other words, Callicutt earned more than 14.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,567 out of 14,666 | 14th |
Division Manufacturing | 4,946 out of 5,768 | 14th |
Major group Chemicals And Allied Products | 1,810 out of 2,074 | 13th |
Industry group Drugs | 1,506 out of 1,730 | 13th |
Industry Pharmaceutical Preparations | 1,164 out of 1,329 | 12th |
Source: SEC filing on April 11, 2018.
Callicutt's colleagues
We found two more compensation records of executives who worked with Jack W. Callicutt at Galectin Therapeutics in 2017.